These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4356419)

  • 1. The metabolism of (ureyl-14C)tolbutamide in vitro and in vivo in man.
    Darby FJ; Grundy RK
    Life Sci; 1973 Jul; 13(2):97-105. PubMed ID: 4356419
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic control of tolbutamide metabolism in humans.
    Scott J; Henderson AD; Poffenbarger PL
    Adv Exp Med Biol; 1979; 119():361-70. PubMed ID: 495292
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism in vitro of (ureyl-14C)-tolbutamide by microsomal preparations from rat and human liver.
    Darby FJ; Evans DA
    Biochem J; 1971 Nov; 125(2):46P-47P. PubMed ID: 5144753
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin A status and hepatic drug metabolism in the rat.
    Becking GC
    Can J Physiol Pharmacol; 1973 Jan; 51(1):6-11. PubMed ID: 4348122
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of pretreatment of mice with norethindrone on the metabolism of 14C-imipramine by the liver microsomal drug-metabolizing enzymes.
    Bellward GD; Morgan RG; Szombathy VH
    Can J Physiol Pharmacol; 1974 Feb; 52(1):28-38. PubMed ID: 4151101
    [No Abstract]   [Full Text] [Related]  

  • 6. The nature of the in vitro irreversible binding of carbon tetrachloride to microsomal lipids.
    Villarruel MC; Díaz Gómez MI; Castro JA
    Toxicol Appl Pharmacol; 1975 Jul; 33(1):106-14. PubMed ID: 240222
    [No Abstract]   [Full Text] [Related]  

  • 7. Imipramine and chlorpromazine in hepatic microsomal systems.
    Perel JM; O'Brien L; Black NB; Bellward GD; Dayton PG
    Adv Biochem Psychopharmacol; 1974; 9(0):201-12. PubMed ID: 4836204
    [No Abstract]   [Full Text] [Related]  

  • 8. Apparent Michaelis constants for the metabolism of (ureyl- 14 C)tolbutamide by human liver microsomal preparations.
    Darby FJ; Grundy RK; Evans DA
    Biochem Pharmacol; 1972 Feb; 21(3):407-14. PubMed ID: 5014495
    [No Abstract]   [Full Text] [Related]  

  • 9. (Ureyl- 14 C) tolbutamide and (2- 14 C) pentobarbitone as substrates for the hepatic microsomal drug-metabolizing enzyme system in vitro.
    Darby FJ; Evans DA
    J Physiol; 1971 Dec; 219(2):7P-8P. PubMed ID: 5158408
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition by ethylmorphine and pentobarbitone in vitro of the metabolism of (ureyl- 14 C)tolbutamide by hepatic microsomal preparations from sexually-immature male and female rats treated with phenobarbitone.
    Darby J
    Biochem Pharmacol; 1973 Apr; 22(8):989-92. PubMed ID: 4693832
    [No Abstract]   [Full Text] [Related]  

  • 11. 12alpha-hydroxylation of 7alpha-hydroxy-4-cholesten-3-one by a reconstituted system from rat liver microsomes.
    Bernhardsson C; Björkhem I; Danielsson H; Wikvall K
    Biochem Biophys Res Commun; 1973 Oct; 54(3):1030-8. PubMed ID: 4148126
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition.
    Knodell RG; Hall SD; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1112-9. PubMed ID: 3598900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dechlorination of chloroethane with a reconstituted liver microsomal system.
    Gandolfi AJ; Van Dyke RA
    Biochem Biophys Res Commun; 1973 Aug; 53(3):687-92. PubMed ID: 4147284
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic factors influencing the metabolism of tolbutamide.
    Back DJ; Orme ML
    Pharmacol Ther; 1989; 44(2):147-55. PubMed ID: 2519343
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
    Veronese ME; McManus ME; Laupattarakasem P; Miners JO; Birkett DJ
    Drug Metab Dispos; 1990; 18(3):356-61. PubMed ID: 1974199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7 -Hydroxylation of taurodeoxycholic acid by a reconstituted system from rat liver microsomes.
    Björkhem I; Danielsson H; Wikvall K
    Biochem Biophys Res Commun; 1973 Jul; 53(2):609-16. PubMed ID: 4716991
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations.
    Miners JO; Smith KJ; Robson RA; McManus ME; Veronese ME; Birkett DJ
    Biochem Pharmacol; 1988 Mar; 37(6):1137-44. PubMed ID: 3355588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.